MetLife Investment Advisors LLC Trims Stake in UnitedHealth Group Inc (UNH)

Share on StockTwits

MetLife Investment Advisors LLC trimmed its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.9% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 291,208 shares of the healthcare conglomerate’s stock after selling 8,630 shares during the quarter. UnitedHealth Group makes up about 0.7% of MetLife Investment Advisors LLC’s investment portfolio, making the stock its 18th largest holding. MetLife Investment Advisors LLC’s holdings in UnitedHealth Group were worth $62,319,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. First Foundation Advisors raised its stake in shares of UnitedHealth Group by 9.0% in the 1st quarter. First Foundation Advisors now owns 12,416 shares of the healthcare conglomerate’s stock valued at $2,657,000 after acquiring an additional 1,020 shares in the last quarter. InterOcean Capital LLC raised its stake in shares of UnitedHealth Group by 166.9% in the 1st quarter. InterOcean Capital LLC now owns 3,264 shares of the healthcare conglomerate’s stock valued at $698,000 after acquiring an additional 2,041 shares in the last quarter. GQG Partners LLC raised its stake in shares of UnitedHealth Group by 10.9% in the 1st quarter. GQG Partners LLC now owns 873,108 shares of the healthcare conglomerate’s stock valued at $186,845,000 after acquiring an additional 86,118 shares in the last quarter. Winslow Capital Management LLC raised its stake in shares of UnitedHealth Group by 9.1% in the 1st quarter. Winslow Capital Management LLC now owns 2,707,193 shares of the healthcare conglomerate’s stock valued at $579,339,000 after acquiring an additional 225,123 shares in the last quarter. Finally, Northstar Capital Management LLC raised its stake in shares of UnitedHealth Group by 4.1% in the 1st quarter. Northstar Capital Management LLC now owns 16,711 shares of the healthcare conglomerate’s stock valued at $3,576,000 after acquiring an additional 657 shares in the last quarter. Institutional investors and hedge funds own 84.85% of the company’s stock.

Shares of NYSE:UNH opened at $254.37 on Monday. UnitedHealth Group Inc has a 1-year low of $183.39 and a 1-year high of $256.73. The company has a market cap of $242.06 billion, a PE ratio of 25.26, a PEG ratio of 1.45 and a beta of 0.74. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.56.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 17th. The healthcare conglomerate reported $3.04 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.91 by $0.13. UnitedHealth Group had a return on equity of 22.06% and a net margin of 5.41%. The company had revenue of $55.19 billion for the quarter, compared to analyst estimates of $54.90 billion. During the same quarter last year, the firm earned $2.37 EPS. UnitedHealth Group’s revenue for the quarter was up 13.3% compared to the same quarter last year. research analysts expect that UnitedHealth Group Inc will post 12.62 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 26th. Stockholders of record on Monday, June 18th will be issued a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a dividend yield of 1.42%. The ex-dividend date is Friday, June 15th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $0.75. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.75%.

UnitedHealth Group announced that its Board of Directors has approved a stock buyback plan on Wednesday, June 6th that authorizes the company to repurchase 100,000,000 outstanding shares. This repurchase authorization authorizes the healthcare conglomerate to reacquire shares of its stock through open market purchases. Shares repurchase plans are often an indication that the company’s board of directors believes its shares are undervalued.

A number of research analysts recently weighed in on UNH shares. Cantor Fitzgerald reissued a “buy” rating and issued a $280.00 price objective on shares of UnitedHealth Group in a research note on Thursday, March 8th. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $240.00 price objective on the stock in a research note on Tuesday, April 3rd. Credit Suisse Group reissued a “buy” rating on shares of UnitedHealth Group in a research note on Friday, March 9th. Piper Jaffray Companies reissued a “buy” rating and issued a $270.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 18th. Finally, Royal Bank of Canada reissued a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday, April 18th. One equities research analyst has rated the stock with a hold rating and twenty-seven have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $259.88.

In other news, Director Kenneth Irwin Shine sold 202 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, April 19th. The stock was sold at an average price of $237.42, for a total transaction of $47,958.84. Following the sale, the director now owns 28,948 shares of the company’s stock, valued at approximately $6,872,834.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction that occurred on Monday, May 21st. The stock was sold at an average price of $248.82, for a total value of $3,732,300.00. Following the sale, the director now directly owns 1,746,533 shares in the company, valued at approximately $434,572,341.06. The disclosure for this sale can be found here. Insiders have sold a total of 49,854 shares of company stock worth $12,295,675 in the last three months. 0.87% of the stock is owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Cowen Reaffirms Hold Rating for Parker-Hannifin
Cowen Reaffirms Hold Rating for Parker-Hannifin
Stifel Nicolaus Reaffirms “Buy” Rating for Facebook, Inc. Common Stock
Stifel Nicolaus Reaffirms “Buy” Rating for Facebook, Inc. Common Stock
Parsley Energy Inc Forecasted to Post Q2 2018 Earnings of $0.33 Per Share
Parsley Energy Inc Forecasted to Post Q2 2018 Earnings of $0.33 Per Share
Analysts Offer Predictions for Resolute Energy Corp’s Q2 2018 Earnings
Analysts Offer Predictions for Resolute Energy Corp’s Q2 2018 Earnings
1347 Property Insurance Holdings Inc  Expected to Earn Q2 2018 Earnings of $0.05 Per Share
1347 Property Insurance Holdings Inc Expected to Earn Q2 2018 Earnings of $0.05 Per Share
Q2 2018 EPS Estimates for Alaris Royalty Corp. Reduced by National Bank Financial
Q2 2018 EPS Estimates for Alaris Royalty Corp. Reduced by National Bank Financial


Leave a Reply

 
© 2006-2018 Zolmax.